Pharmaceutical process engineers are vital professionals who design, optimize, and scale up the manufacturing processes of pharmaceutical products. Their main focus is to ensure that drug production is efficient, cost-effective, and meets stringent quality standards. These engineers apply principles of chemical engineering, mechanical engineering, and pharmaceutics to develop processes that convert raw materials into finished dosage forms, such as tablets, capsules, injectables, or ointments. By carefully controlling parameters like temperature, pressure, mixing speed, and drying conditions, pharmaceutical process engineers help maintain consistency, purity, and potency of the medications. They also work to enhance production yield, minimize waste, and comply with regulatory requirements, making their role crucial in bringing safe and effective drugs to the market.
Beyond process design, pharmaceutical process engineers are deeply involved in troubleshooting manufacturing challenges, implementing process analytical technologies (PAT), and advancing continuous manufacturing techniques to improve efficiency and reduce costs. Their expertise is critical in technology transfer between research and development (R&D) and commercial manufacturing sites. Additionally, they collaborate closely with quality assurance teams to validate processes and ensure compliance with good manufacturing practices (GMP). As the pharmaceutical industry evolves with emerging technologies and stricter regulations, pharmaceutical process engineers remain essential for optimizing production workflows, enhancing product quality, and ensuring the timely delivery of life-saving medicines worldwide.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia